Evidence map›Paper›PMID 32044981›Full record

ArticleRheumatology (Oxford, England)2020

Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control study.

Jolien F van Nimwegen, Karin van der Tuuk, Silvia C Liefers, Gwenny M Verstappen, Annie Visser, Robin F Wijnsma, Arjan Vissink, Harry Hollema, Marian J E Mourits, Hendrika Bootsma and 1 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07153276 (TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07153276 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Treatment of vaginal dryness in sjögren's disease with co2-laser versus topical promestriene: a prospective randomized study

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2026 to 2030Enrolled60ConditionsSjogren Syndrome, Sjogren Disease, Primary Sjogren SyndromeArmsFractional CO2 laser (vaginal), Promestriene Vaginal
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Kidney manifestations of pediatric Sjögren's syndrome.Pediatric nephrology (Berlin, Germany) · 2024
    Article
  5. Review
  6. Therapeutic potential for P2YPurinergic signalling · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Unique Aspects of Pediatric Sjögren Disease.Rheumatic diseases clinics of North America · 2021
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jolien F van NimwegenDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Karin van der TuukDepartment of Obstetrics and Gynaecology, University of GroningenUniversity Medical Center Groningen, Groningen, The Netherlands.
Silvia C LiefersDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Gwenny M VerstappenDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Annie VisserDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Robin F WijnsmaDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Arjan VissinkDepartment of Oral and Maxillofacial Surgery University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Harry HollemaDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Marian J E MouritsDepartment of Obstetrics and Gynaecology, University of GroningenUniversity Medical Center Groningen, Groningen, The Netherlands.
Hendrika BootsmaDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Frans G M KroeseDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim was to study clinical, histopathological and immunological changes in the vagina and cervix of women with primary SS, which might explain vaginal dryness.

methodsWe included 10 pre-menopausal female primary SS patients with vaginal dryness and 10 pre-menopausal controls undergoing a laparoscopic procedure. The vaginal health index was recorded. Multiplex immunoassays and flow cytometry were performed on endocervical swab and cervicovaginal lavage samples to evaluate cellular and soluble immune markers. Mid-vaginal and endocervical biopsies were taken and stained for various leucocyte markers, caldesmon (smooth muscle cells), avian V-ets erythroblastosis virus E26 oncogene homologue (ERG; endothelial cells) and anti-podoplanin (lymphatic endothelium). The number of positive pixels per square micrometre was calculated.

resultsOne patient was excluded because of Clamydia trachomatis, and two controls were excluded because of endometriosis observed during their laparoscopy. Vaginal health was impaired in primary SS. CD45+ cells were increased in vaginal biopsies of women with primary SS compared with controls. Infiltrates were predominantly located in the peri-epithelial region, and mostly consisted of CD3+ lymphocytes. In the endocervix, CD45+ infiltrates were present in patients and in controls, but a higher number of B lymphocytes was seen in primary SS. Vascular smooth muscle cells were decreased in the vagina of primary SS patients. No differences were found in leucocyte subsets in the vaginal and endocervical lumen. CXCL10 was increased in endocervical swab samples of primary SS patients.

conclusionWomen with primary SS show impaired vaginal health and increased lymphocytic infiltration in the vagina compared with controls. Vaginal dryness in primary SS might be caused by vascular dysfunction, possibly induced by IFN-mediated pathways.

Indexed as

AdultB-LymphocytesCase-Control StudiesCervix UteriChemokine CXCL10Endothelial CellsFemaleFlow CytometryHumansLaparoscopyLymphocyte SubsetsMiddle AgedProspective StudiesSjogren's SyndromeVaginaVaginal DiseasesChemokine CXCL10CXCL10 protein, humanCXCL10gynaecologyinterferonlymphocytespathogenesisSjögren’s syndromesmooth muscle cellsvaginal drynessvaginal health

Identifiers

PMID32044981
PMCPMC7516088
OpenAlexW3006367840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.